IPO Funding Source: Connect with Investors for Your Public Offering
Raise capital for your initial public offering with DealStream’s premier IPO funding network. Our platform connects entrepreneurs with top investment banks, underwriters, institutional investors, and venture capitalists actively financing IPOs. Streamline your pre-IPO fundraising, tap into exclusive investor networks, and accelerate your path to going public. Get started today to secure the funding you need for a successful IPO.
Showcased Deals
Delaware Company - Nasdaq Or Nyse Listing Options
SPACs cost north of 1.5 million in addition to about 30% equity dilution by SPAC sponsors and bankers, but this exceptionally clean Delaware company doesn’t come with this inherited substantial dilution as the SPAC. We specialize in institutional funding for up to 350 million post-listing, collateralized...
Pre-Funded NASDAQ Direct Listing: $25M–$750M ELOC
Seize a rare opportunity to back a company poised for a Direct NASDAQ Listing, fully supported by an Equity Line of Credit (ELOC) pre-commitment of $25 million to $750 million. This dual-offering not only streamlines your entry into the public markets but also guarantees growth capital on day one of...
Institutional ELOC Funding / Direct NASDAQ Listing
Our institutional Equity Line of Credit (ELOC) solution is designed to support exchange-listed companies with seamless access to capital post-listing, ensuring liquidity and strategic expansion without the dilution risks of traditional financing. Pre-Arranged ELOC Facility: Gain access to a structured...
All Matching Deals
List On The Nasdaq Or Nyse, And Get Funded
To attract capital from institutional investors for up to $350 million under an ELOC post-NASDAQ listing, we undertake a Direct continuance offering, occasionally referred to as a "Shelf Offering." The continuance offering is a very tempting technique of acquiring finance since the company will...
Delaware Company - Nasdaq Or Nyse Listing Options
SPACs cost north of 1.5 million in addition to about 30% equity dilution by SPAC sponsors and bankers, but this exceptionally clean Delaware company doesn’t come with this inherited substantial dilution as the SPAC. We specialize in institutional funding for up to 350 million post-listing, collateralized...
$350m In Post-Listing Finance Via A Shelf Offering
Shelf Offering or S-3/S-1 registration statement allows a company to register securities with the Securities and Exchange Commission (SEC) and sell them over time without having to go through the entire registration process each time. This can be an attractive option for companies looking to raise capital...
Institutional ELOC Funding / Direct NASDAQ Listing
Our institutional Equity Line of Credit (ELOC) solution is designed to support exchange-listed companies with seamless access to capital post-listing, ensuring liquidity and strategic expansion without the dilution risks of traditional financing. Pre-Arranged ELOC Facility: Gain access to a structured...
SPACs Seeking Qualified Merger Targets
We are seeking qualified merger targets for our US SPACs. Two entities are trading and ready for deSPAC. One entity is fully approved SPAC not trading; ready for IPO. Alternative bridge financing solutions and post-merger finance available.
Pre-Funded NASDAQ Direct Listing: $25M–$750M ELOC
Seize a rare opportunity to back a company poised for a Direct NASDAQ Listing, fully supported by an Equity Line of Credit (ELOC) pre-commitment of $25 million to $750 million. This dual-offering not only streamlines your entry into the public markets but also guarantees growth capital on day one of...
Equity Swaps - Go Company Public Almost Free
We are a Florida based M&A firm with over 17 years public markets experience. Currently we have several very clean publicly traded Vehicles looking for all equity swap. No real estate deals, crypto currency, marijuana, hemp or similar type of companies please. We are looking for real companies...
Want To Be A NASDAQ Traded Public Company
We have been taking companies public through IPO's and reverse mergers for over 22 years. We specialize in small to medium sized IPO's. We work with one of the oldest investment banking firms taking companies public through IPO's ranging from $10 million - $150 million and raising capital prior to the...
Raise MIllions-IPO-LBO-Conv Debt-Combos-Consultant
We will introduce you to the right players in the money arena. $10M to $500M. No Upfront fees. Contact us.
Attention Experienced Real Estate Investors
Do you have a business with strong cash flow? It's time to partner with a lender who truly understands your needs! Specialized financing solutions tailored for savvy investors like you" If you're a growth-stage company with real revenue and a clear path to scaling, we can help you access substantial...
Investment Into Biotech and Pharma Companies
We are able to arrange equity funding from investment funds based on further company EU or NASDAQ listing condition. Funding will be secured before company is going public by binding investment agreement(s) and will be available after listing is done and company traded based on share price and liquidity...
Dual Listing To Frankfurkt And Capital Raising
We are offering a dual listing and capital raising with the Frankfurt Stock Exchange qoutation board for the public companies listed at this stock markets : Abu Dhabi Securities Exchange Cyprus Stock Exchange NASDAQ Riga Amman Stock Exchange Aquis Stock Exchange Armenia Stock Exchange Athens Stock...
In-Kind IPO Investor in the Biotech/Pharma IPO
Company is a leading in-kind investor in IPO of the biotech and drug discovery companies in the USA, France, Austria, and the UK. We believe that these sectors hold great potential for growth and innovation, and we are proud to support these companies as they work to bring their ideas to market. Company...
Funding Clinical-Stage Drug Development Companies
Thank you for being in touch! As backstop investors we are focused on capital markets and offering a true alternative that really works to the traditional VC investment, allowing companies to have a Plan B in case VC funding becomes challenging or VC valuations do not meet expectations. We are investing...
Alternative to VC funding for European business
Going public (through an IPO) versus raising capital from venture capital (VC) each comes with distinct advantages, especially for companies ready to make that decision. Here’s an outline of the key benefits of going public: 1. Access to Larger Capital Pools Broad Investor Base: An IPO allows a...
Alternative to the VC funding to the TECH sector
We are leading in-kind tech IPO investors since 2006 providing the capital alternative to the debt, private equity or VC funding. Advantages of Capital Markets Over VCs: 1. Broader Access to Funding o Capital Markets: Access to a global pool of investors, including retail investors, institutional...
Bridge Funding For IPO (European Based)
Our firm specializes in financing direct public offering (direct listing) for companies in the technology sector seeking to list on European stock exchanges. We are particularly interested in companies from US and Europe within the following areas: AI, Cybersecurity, Space, quantum computing, artificial...
Monetizing Securities
We have a licensed source of capital to provide loans on various assets: Stocks, free and unrestricted trading on national exchanges, no pink sheets or gem stocks contact for more information about loans on stocks as collateral SPAC's loans for stocks no restrictions, free and unrestricted shares...
Funding For Securities Trading On Exchanges
Loan amounts from 1M USD and increasing to 1B Loan to values to 75% with fixed annual interest rates as low as 2.5% Loan terms 36 months to 120 months with monthly interest only payment structures This is a licensed fund with ability to fund in a variety of currencies in addition to USA 100% non-title...
Tokenise Your Company’s Shares
The development of new international standards has facilitated issuance of token based shares (blockchains) on centralised or decentralised ledger technologies, and opened for additional financing opportunities for a large number of companies. We offer every company a turn-key solution to, wholly...
Canadian Special Purpose Vehicle for Sale
Attention: Canadian Private Companies considering going public we have a solution for you. Financing included. Will need a budget for initial costs. SPV is poised for listing on the CSE, OTC, Frankfurt Exchanges.
Private/Public Funds for Tech/Pharma/Medical Co's
Investment Bank/Private Equity/Family Office funds seeking opportunities in the following spaces: Technology: Blockchain. Communications. Supply Chain. Biopharmaceutical: Clinical Stage. All areas. Pipeline. Phase 2+ Medical: Device. Delivery. Software. Supply. Minimum Investment $10 million....
Investment Opportunity Scalable Affordable Housing
OTC PINK CURRENT INVESTMENT OPPORTUNITY Mobile Home Park Acquisition & Uplisting Strategy Overview We are a Pink Current OTC company executing a disciplined acquisition strategy in the Mobile Home Park (MHP) sector—one of the most resilient, cash-flow-driven asset classes in U.S. real estate. The...
IPO vs Rev Merger? Undecided? Call Me - 35 Yrs Exp
IPO? REVERSE MERGER? 35 years of experience will save you a lot of time. If you are a cash flow generating company OR you are a start up in a huge space with unlimited potential, call us. Sometimes instant funding. NO UPFRONT FEES.
Raising Capital with Opportunity Zone Funds
Raising Capital with Opportunity Zone Funds Turnkey OZ Fund Development Let our team of experts set up your Opportunity Zone Fund for: •Real Estate •Energy •Education •Retail •Manufacturing •Community Development •Technology •Hospitality •Biotech •New Land Development •Aerospace •Aviation •Utilities •Infrastructure •Industrial...
Pros And Cons Of Public Offering Financing
Access to Significant Capital
One of the main advantages of pursuing public offering financing is the ability to raise substantial capital in a relatively short period. By issuing shares to the public through an Initial Public Offering (IPO), a business can tap into a vast pool of investors, enabling larger projects, acquisitions, or rapid expansion. Public offerings also tend to boost the company's profile, credibility, and market presence, which can create additional business opportunities and partnerships.
Enhanced Liquidity and Exit Options
Another benefit comes in the form of improved liquidity for existing shareholders. When a company is publicly traded, owners and early investors have an accessible, regulated market where they can sell their shares and potentially realize gains from their investment. This liquidity makes public companies more attractive to both current and prospective investors, and also provides a possible exit strategy for founders or venture capital backers looking to divest.
Increased Disclosure and Regulatory Burden
Despite the advantages, public offering financing comes with significant drawbacks. One of the largest is the substantial cost and complexity associated with regulatory compliance. Public companies must adhere strictly to financial reporting standards and are required to disclose detailed information about their operations, finances, and strategy. This level of transparency not only incurs legal and administrative costs but also exposes the business to greater public scrutiny from regulators, investors, and competitors. Ultimately, for some mid-sized businesses, these burdens may outweigh the benefits of raising capital through a public offering.